Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

150%

3 of 2 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03705000Not ApplicableTerminated

SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction

Role: lead

NCT00917553Phase 2Completed

Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy

Role: lead

NCT00511875Phase 2Completed

Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy

Role: lead

All 3 trials loaded